Atlas Trials

Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia

Clinical trial NCT01016340 · TERMINATED

Trial details

NCT number
NCT01016340
Sponsor
Health Ever Bio-Tech Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Male Oligoasthenospermia
Start date
2009-12-01
Primary completion
2012-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.